NVAX

Lobbying Update: $100,000 of NOVAVAX INC lobbying was just disclosed

$100,000 of NOVAVAX INC lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to COVID-19 vaccines Reauthorization of Pandemic and All-Hazards Preparedness Act General discussions related to vaccine injury compensation programs and vaccine strain selection timelines. H.R.9027/S.4690 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act"

You can find more data on corporate lobbying on Quiver Quantitative.

NVAX Insider Trading Activity

NVAX insiders have traded $NVAX stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $NVAX stock by insiders over the last 6 months:

  • JAMES F YOUNG has made 0 purchases and 2 sales selling 10,000 shares for an estimated $82,208.
  • RACHEL K. KING sold 4,150 shares for an estimated $37,435

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NVAX Hedge Fund Activity

We have seen 102 institutional investors add shares of NVAX stock to their portfolio, and 95 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.


This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.